Unrelated Donor Stem Cell Transplantation
The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.
Severe Aplastic Anemia|Paroxysmal Nocturnal Hemoglobinuria|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Myeloproliferative Syndromes|Chronic Myelogenous Leukemia|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Multiple Myeloma|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Large Granulocytic Leukemia
PROCEDURE: Allogeneic transplantation
Bone Marrow and Peripheral Blood Chimerism, Percent of donor and host cells in peripheral blood and bone marrow will be measured by short tandem repeat (STR) testing and/or standard cytogenetic testing., 30 days post-transplant|Bone Marrow and Peripheral Blood Chimerism, Percent of donor and host cells in peripheral blood and bone marrow will be measured by short tandem repeat (STR) testing and/or standard cytogenetic testing., 100 days post-transplant|Bone Marrow and Peripheral Blood Chimerism, Percent of donor and host cells in peripheral blood and bone marrow will be measured by short tandem repeat (STR) testing and/or standard cytogenetic testing., 365 days post-transplant
same